PepDiana
Back to Evidence
Primary experimental recordNegative / threshold

PMC9715947::ACT054548

HAZ

Evidence text

Paper-level observation

Section 3.5: more than 95 % viability inhibition achieved by treatment with 10 µM.
textConfidence: medium

Assay observation

Activity
Anticancer
Subtype
Cytotoxic
Measure
cell_viability
Comparator
<
Raw observation
more than 95 % viability inhibition achieved by treatment with 10 µM
Normalized measurement
<5%
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Homo sapiens
Assay method
Not reported by source
Sequence
GVKFAKRFWRFAKKAFKRFEK
Standardization
ready simple

Source publication

HAZ, a novel peptide with broad-spectrum antibacterial activity

Saudi Pharmaceutical Journal · 2022

DOI 10.1016/j.jsps.2022.09.009 PMC9715947
Parent mention

Related peptide identities

PEPDIA-PLP-001133

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.